[CONFERENCE POSTER]: Benefit of intravenous injection of clinical grade mesenchymal stem cells after experimental stroke.
F1000 Poster Based on: Neuroscience Meeting. 2010:57.13
Michael Moskowitz1 and Johannes Boltze2
06 Jan 2011
Mesenchymal stem cells (MSCs) were shown to have a beneficial impact following stroke in animal models and are on the brink of clinical testing. However, subsequent steps of translation, like the use of cells being manufactured under conditions of good manufacturing practice (GMP) have not been reported so far. This study is interesting...
INDIVIDUAL SUBSCRIPTIONS
Get instant access to Article Recommendations from more than 5,000 expert scientists and clinical researchers, assisted by 5,000 associates, by taking out a monthly subscription. The first month of your subscription will be free of charge.
Start your personal subscription today.
Subscribe for $9.95/monthINSTITUTIONAL SUBSCRIPTIONS
Send a recommendation to your institution's librarian or information manager to request an extended free trial for all users.
Recommend to your LibrarianIf you are a librarian or information manager, you may request an extended free trial for your academic or corporate institution.
Request an Institutional Trialyour institution might be eligible for free access via our sponsorship scheme. Check our sponsorship page.
If you think you should be able to access this content, please contact us.